Medtech deal value nearly doubled from 2024 to 2025 to $33 billion and volume grew nearly 20% to approximately 88 deals.

Pittsburgh-based insurer Highmark is further expanding its drug offerings through CivicaScript and leaning on biosimilars as ...

The state of Utah has embarked on the first test of artificial intelligence as an autonomous clinical decision-maker under a ...

The challenge in community health isn’t just providing access to specialists; it’s also bridging the gap between primary and ...